Literature DB >> 24513117

Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms.

Reza Rastmanesh1, Jalal Hejazi2, Francesco Marotta3, Noboru Hara4.   

Abstract

Diabetes mellitus and prostate cancer are 2 of the most important public health concerns, especially in the elderly population. Although diabetes has been recognized as a potent risk factor for many types of cancers, there is a large amount of evidence that shows that it has a protective role against prostate cancer. The underlying cause of this protective role is not fully understood, however, some mechanisms have been proposed in this area. In the present study we have reviewed these mechanisms and some new mechanisms are also proposed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCL14; Insulin; Insulin-like growth factor-1; Metformin; Testosterone

Mesh:

Substances:

Year:  2014        PMID: 24513117     DOI: 10.1016/j.clgc.2014.01.001

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  9 in total

1.  Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy.

Authors:  Nicholas G Zaorsky; Talha Shaikh; Karen Ruth; Pankaj Sharda; Shelly B Hayes; Mark L Sobczak; Mark A Hallman; Marc C Smaldone; David Y T Chen; Eric M Horwitz
Journal:  Clin Genitourin Cancer       Date:  2016-09-08       Impact factor: 2.872

2.  Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.

Authors:  Amina Amadou; Heinz Freisling; Mazda Jenab; Konstantinos K Tsilidis; Antonia Trichopoulou; Paolo Boffetta; Bethany Van Guelpen; Olatz Mokoroa; Tom Wilsgaard; Frank Kee; Ben Schöttker; José M Ordóñez-Mena; Satu Männistö; Stefan Söderberg; Roel C H Vermeulen; J Ramón Quirós; Linda M Liao; Rashmi Sinha; Kari Kuulasmaa; Hermann Brenner; Isabelle Romieu
Journal:  Br J Cancer       Date:  2021-03-26       Impact factor: 7.640

3.  Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer.

Authors:  Kerri Beckmann; Danielle Crawley; William G Nelson; Elizabeth A Platz; Elizabeth Selvin; Mieke Van Hemelrijck; Sabine Rohrmann
Journal:  Cancer Causes Control       Date:  2022-01-21       Impact factor: 2.532

4.  The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study.

Authors:  Jin Bong Choi; Hyong Woo Moon; Young Hyun Park; Woong Jin Bae; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Kyung-Do Han; U-Syn Ha
Journal:  J Cancer       Date:  2016-10-22       Impact factor: 4.207

5.  Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.

Authors:  Christel Häggström; Mieke Van Hemelrijck; Björn Zethelius; David Robinson; Birgitta Grundmark; Lars Holmberg; Soffia Gudbjörnsdottir; Hans Garmo; Pär Stattin
Journal:  Int J Cancer       Date:  2016-11-03       Impact factor: 7.396

Review 6.  Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Christopher B Chen; Maxim Eskin; Dean T Eurich; Sumit R Majumdar; Jeffrey A Johnson
Journal:  BMC Cancer       Date:  2018-01-10       Impact factor: 4.430

Review 7.  The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer.

Authors:  André P Sousa; Raquel Costa; Marco G Alves; Raquel Soares; Pilar Baylina; Rúben Fernandes
Journal:  Front Cell Dev Biol       Date:  2022-03-25

8.  Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.

Authors:  Jee Soo Park; Kwang Suk Lee; Won Sik Ham; Byung Ha Chung; Kyo Chul Koo
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Pleiotropic Effects of Metformin on Cancer.

Authors:  Hans-Juergen Schulten
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.